TY  - JOUR
T1  - POtential target for als therapy
AU  - Hampton T
Y1  - 2012/10/03
N1  - 10.1001/jama.2012.13154
JO  - JAMA
SP  - 1310
EP  - 1310
VL  - 308
IS  - 13
N2  - 
The researchers identified mutations that disrupt the expression or function of EPHA4 in 2 unrelated long-surviving individuals with ALS, suggesting that loss of EPHA4 may be protective.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2012.13154
UR  - http://dx.doi.org/10.1001/jama.2012.13154
ER  -